Ternary Therapeutics

Ternary Therapeutics is a biotech company in London, United Kingdom, founded in 2024. It has raised $4.4M across 1 round, most recently a $4.4M Seed in March 2026.

Molecular glues, engineered from the surface up

Headquarters
London
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$4.4M
Last Round
$4.4M SeedMar 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Ternary Therapeutics (TernaryTx) is a London-based biotech company founded in 2024 that uses frontier AI and deep physics to design molecular glue therapeutics — small molecules that work by glueing two proteins together. Its proprietary four-engine computational platform (Leopard, Puffin, Gecko, Octopus) combines machine learning, physics-based molecular modelling, and rapid laboratory testing to turn molecular glue drug discovery from a chance-based process into a repeatable engineering system. The company has a pipeline of preclinical programmes in inflammatory and neuroinflammatory diseases and raised a €4.1 million seed round in March 2026 led by daphni.

Summary

It lists 1–10 employees. It has raised $4.4M in total across 1 round, most recently a $4.4M Seed round in Mar 2026. Investors include Daphni, Pace Ventures and UK Innovation & Science Seed Fund.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundMar 2026
$4.4M

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ternary Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ternary-therapeutics"><img src="https://indexed.vc/api/badge/company/ternary-therapeutics" alt="Ternary Therapeutics on Indexed.vc" width="260" height="76" /></a>